Asacol and agranulocytosis Patient Reports February 09, 2010

Asacol Side Effects Report #5131017-X
Asacol side effect was reported by a Physician from UNITED STATES on June 14, 2006. Female patient, 54 years of age, was diagnosed with colitis ulcerative and was treated with Asacol. After drug was administered, patient experienced the following side effects: agranulocytosis, neutropenia, pancytopenia. Asacol dosage: 1600 MG, TWICE DAILY, ORAL. During the same period patient was treated with LASIX, POTASSIUM CHLORIDE, EFFEXOR, EXCEDRIN, ZYRTEC, ROWASA, PRILOSEC, SINGULAIR. Patient recovered.

Asacol Side Effects Report #5131140-X
Asacol side effect was reported by a Physician from UNITED STATES on June 14, 2006. Female patient, 54 years of age, was diagnosed with colitis ulcerative and was treated with Asacol. After drug was administered, patient experienced the following side effects: agranulocytosis, neutropenia, pancytopenia. Asacol dosage: 1600 MG, TWICE DAILY, ORAL. During the same period patient was treated with LASIX, POTASSIUM CHLORIDE, EFFEXOR, EXCEDRIN, ZYRTEC, ROWASA, PRILOSEC, SINGULAIR. Patient recovered.

Asacol Side Effects Report #4693944-7
Asacol side effect was reported by a Physician from on June 01, 2005. Female patient, 78 years of age, weighting 143.1 lb, was diagnosed with colitis and was treated with Asacol. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, asthenia, atelectasis, back pain , bicytopenia, biliary tract disorder, bone marrow depression, cardiac failure congestive. Asacol dosage: 2400 MG DAILY, ORAL. During the same period patient was treated with PREDNISONE, ADVAIR, COZAAR, BENICAR, ACIPHEX, PANCREASE, SINGULAIR. Patient recovered.

Asacol Side Effects Report #5899301-X
Asacol side effect was reported by a Physician from UNITED STATES on June 17, 2008. Female patient was treated with Asacol. After drug was administered, patient experienced the following side effects: agranulocytosis. Asacol dosage: unknown. Patient recovered.